ZA200210230B - Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine. - Google Patents

Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine.

Info

Publication number
ZA200210230B
ZA200210230B ZA200210230A ZA200210230A ZA200210230B ZA 200210230 B ZA200210230 B ZA 200210230B ZA 200210230 A ZA200210230 A ZA 200210230A ZA 200210230 A ZA200210230 A ZA 200210230A ZA 200210230 B ZA200210230 B ZA 200210230B
Authority
ZA
South Africa
Prior art keywords
prrsv
vaccine
respiratory syndrome
syndrome virus
porcine reproductive
Prior art date
Application number
ZA200210230A
Other languages
English (en)
Inventor
Audonnet Jean-Christop Francis
Bublot Michel Joseph Marie
Perez Jenifer Maria
Phillippe Guy Nicolas Baudu
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Publication of ZA200210230B publication Critical patent/ZA200210230B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200210230A 2000-05-24 2002-12-18 Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine. ZA200210230B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20665500P 2000-05-24 2000-05-24

Publications (1)

Publication Number Publication Date
ZA200210230B true ZA200210230B (en) 2003-10-27

Family

ID=22767352

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200210230A ZA200210230B (en) 2000-05-24 2002-12-18 Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine.

Country Status (12)

Country Link
US (1) US20030003112A1 (zh)
EP (1) EP1283718A2 (zh)
JP (1) JP2003533989A (zh)
KR (1) KR20030036194A (zh)
CN (1) CN1443076A (zh)
AU (1) AU2001256582A1 (zh)
BR (1) BR0111366A (zh)
CA (1) CA2409874A1 (zh)
MX (1) MXPA02011545A (zh)
PL (1) PL360096A1 (zh)
WO (1) WO2001089559A2 (zh)
ZA (1) ZA200210230B (zh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7445924B2 (en) 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
US7628980B2 (en) 2000-11-23 2009-12-08 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
CN101676389A (zh) 2000-11-23 2010-03-24 巴法里安诺迪克有限公司 改良安卡拉痘苗病毒变体
MXPA03007751A (es) * 2001-03-09 2004-11-12 Boehringer Ingelheim Vetmed Cepas vivas atenuadas del virus prrs.
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) * 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7906311B2 (en) 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
DE60314823T3 (de) 2002-04-19 2017-11-16 Bavarian Nordic A/S Modifizierte variante des vaccinia ankara virus als impfstoff für neugeborene
DK1434858T4 (en) 2002-09-05 2019-04-01 Bavarian Nordic As PROCEDURE FOR AMPLIFICATION OF A POXVIRUS UNDER SERUM-FREE CONDITIONS
DK1594970T3 (da) * 2003-02-18 2008-11-17 Helmholtz Zentrum Muenchen Fremgangsmåde til generering af rekombinant MVA
JP2005075752A (ja) * 2003-08-29 2005-03-24 Nippon Inst For Biological Science 豚繁殖・呼吸障害症候群用ワクチン製剤
US7730482B2 (en) * 2004-06-08 2010-06-01 Covia Labs, Inc. Method and system for customized programmatic dynamic creation of interoperability content
US7527960B2 (en) 2004-06-25 2009-05-05 Merial Limited Avipox recombinants expressing foot and mouth disease virus genes
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
EP1792996A1 (en) * 2005-12-01 2007-06-06 Consejo Superior de Investigaciones Cientificas Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV)
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
WO2009029130A2 (en) * 2007-05-30 2009-03-05 Wyeth Raccoon poxvirus expressing genes of porcine virus
CL2008001806A1 (es) * 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
US8398970B2 (en) 2007-09-17 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early Lawsonia intracellularis infections
KR101420850B1 (ko) * 2011-05-30 2014-08-13 건국대학교 산학협력단 돼지 생식기 호흡기 증후군 바이러스 유사입자 및 이를 이용한 백신
CA2837375C (en) * 2011-06-01 2019-07-16 Merial Limited Needle-free administration of prrsv vaccines
BR112017002496A2 (pt) * 2014-08-08 2018-02-20 Idemitsu Kosan Co agente de controle contra a síndrome reprodutiva e respiratória porcina
DE102015111756A1 (de) 2015-07-20 2017-01-26 Eberhard Karls Universität Tübingen Medizinische Fakultät Rekombinanter Orf-Virus-Vektor
CN107236824A (zh) * 2017-06-29 2017-10-10 新希望六和股份有限公司 一种用于猪繁殖与呼吸综合征病毒特异性检测的荧光定量rt‑pcr试剂盒及应用
CN115989030A (zh) * 2020-05-29 2023-04-18 康涅狄格大学 猪繁殖与呼吸综合征病毒的抑制剂
CN116333060B (zh) * 2023-05-15 2023-07-21 广州悦洋生物技术有限公司 猪繁殖与呼吸综合征病毒gp5蛋白及其制备方法和用途、基因、试剂盒和检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100242671B1 (ko) * 1991-03-07 2000-03-02 고돈 에릭 유전학적으로 처리한 백신 균주
DK53595A (da) * 1994-05-13 1995-11-14 Iberica Cyanamid Rekombinante PRRSV-proteiner, diagnostiske kits og vaccine indeholdende sådanne rekombinante PRRSV-proteiner
JPH11507241A (ja) * 1995-06-07 1999-06-29 シントロ・コーポレーション 組換え鶏痘ウイルスおよびその使用
FR2775601B1 (fr) * 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves

Also Published As

Publication number Publication date
US20030003112A1 (en) 2003-01-02
MXPA02011545A (es) 2003-06-06
EP1283718A2 (en) 2003-02-19
KR20030036194A (ko) 2003-05-09
BR0111366A (pt) 2003-05-20
WO2001089559A3 (en) 2002-04-11
CN1443076A (zh) 2003-09-17
JP2003533989A (ja) 2003-11-18
AU2001256582A1 (en) 2001-12-03
PL360096A1 (en) 2004-09-06
CA2409874A1 (en) 2001-11-29
WO2001089559A2 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
ZA200210230B (en) Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine.
HK1029140A1 (en) Infectious cdna clone or north american porcine reproductive and respiratory syndrome (prrs)virus and uses thereof.
AU7960598A (en) Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
EP0595436A3 (en) Swine virus, pathogen of the multiplying respiratory disease, vaccines and its viral DNA.
PL1951882T3 (pl) Kwasy nukleinowe kodujące szczepionkę przeciwko wirusowi wywołującemu zespół zaburzeń reprodukcyjnych i oddechowych u świń
ATE275631T1 (de) Rekombinanter venezolanische-equine- pferdeenzephalitis-virusimpstoff
AU4932601A (en) Recombinant parainfluenza virus expression systems and vaccines
BRPI9911870B8 (pt) vacina de parvovírus e circovírus de suíno
HUT74824A (en) Para-influenza virus-containing vaccines for preventing porcine reproductive and respiratory syndrome
HUP9801124A3 (en) New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (prrs), vaccines and diagnostic means obtainable with said strain, and production process
AU3512797A (en) Porcine reproductive and respiratory syndrome vaccine
AU6086300A (en) Recombinant envelope vaccine against flavivirus infection
AU7501898A (en) Live attenuated virus vaccines for equine encephalitis viruses
EP1794329A4 (en) ISOLATES OF PORCINE RESPIRATORY DYSGENESIS SYNDROME (SDRP), AND METHODS OF USE
EP1305438A4 (en) IMPROVED VIRUS-SIMILAR PARTICLES BUILDING ON THE HEPATITIS B SMALL SLEEP PROTEIN
DE69839169D1 (de) Aus infektiöser cDNA gewonnene rekombinate YF Viren-Impfstoffe
AU4556597A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
ZA971663B (en) Porcine reproductive and respiratory syndrome vaccine.
IL158428A0 (en) Vaccine composition comprising at least one hiv virus antigen
EP1749885B8 (en) Infectious and attenuated bovine viral diarrhea virus vaccine
IL131212A0 (en) Recombinant virus and live-virus vaccines
EP1399481A4 (en) RECOMBINANT ANTIBODIES TO INFECTIOUS BURSAL DISEASE VIRUS (IBDV)
AU2001246331A1 (en) Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof
EP1204424A4 (en) VACCINES AND RECOMBINANT RS VIRUS EXPRESSION SYSTEMS
BR9915703B1 (pt) mutante do vìrus da raiva recombinante, e, vacina anti-rábica atenuada viva.